2026 Creg J. Workman: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	56	3660	3376	1689	1546	126	28539

Creg J. Workman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Creg J. Workman sits on this spectrum.

62 publications 807+

This scientist: 126 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Creg J. Workman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Creg J. Workman sits on this spectrum.

40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Creg J. Workman is affiliated with the University of Pittsburgh in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, focusing on subfields including Immunology, Oncology, Neurology, Molecular Biology, and Infectious Diseases.

The scientist's research topics cover several areas, detailed as follows:

Cancer Immunotherapy and Biomarkers
Immune Cell Function and Interaction
T-cell and B-cell Immunology
Immunotherapy and Immune Responses
CAR-T cell therapy research
COVID-19 Clinical Research Studies
Neuroblastoma Research and Treatments

Workman has a substantial record of publication in multiple venues with recurring contributions to the following journals:

The Journal of Immunology
Regular and Young Investigator Award Abstracts
Nature Immunology
bioRxiv (Cold Spring Harbor Laboratory)
Cell

The scientist's recent notable papers include:

"Interferon-γ: teammate or opponent in the tumour microenvironment?" (2021), published in Nature Reviews. Immunology
"LAG-3 as the third checkpoint inhibitor" (2023), published in Nature Immunology
"Therapeutic targeting of regulatory T cells in cancer" (2022), published in Trends in Cancer
"LAG3 associates with TCR-CD3 complexes and suppresses signaling by driving co-receptor-Lck dissociation" (2022), published in Nature Immunology
"Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment" (2021), published in Frontiers in Immunology

Frequent collaborators in Workman's research include:

Dario A.A. Vignali
Anthony R. Cillo
Tullia C. Bruno
Carly Cardello
Lawrence P. Andrews

Best Publications

How regulatory T cells work.

Dario A. A. Vignali;Lauren W. Collison;Creg J. Workman

4334
Citations
The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Lauren W. Collison;Creg J. Workman;Timothy T. Kuo;Kelli Boyd

2713
Citations
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

Shawn D Blackburn;Haina Shin;W Nicholas Haining;W Nicholas Haining;Tao Zou

2405
Citations
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

Seng Ryong Woo;Meghan E Turnis;Monica V Goldberg;Jaishree Bankoti

1833
Citations
Role of LAG-3 in regulatory T cells.

Ching Tai Huang;Creg J. Workman;Dallas Flies;Xiaoyu Pan

1612
Citations
Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector.

Andrea L Szymczak;Andrea L Szymczak;Creg J Workman;Yao Wang;Kate M Vignali

1446
Citations
IL-35-mediated induction of a potent regulatory T cell population

Lauren W Collison;Vandana Chaturvedi;Abigail L Henderson;Abigail L Henderson;Paul R Giacomin

1062
Citations
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3

Xiaobo Mao;Michael Tianhao Ou;Senthilkumar S. Karuppagounder;Tae In Kam

756
Citations
Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis

Greg M. Delgoffe;Seng-Ryong Woo;Meghan E. Turnis;David M. Gravano

653
Citations
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity

Abigail E. Overacre-Delgoffe;Abigail E. Overacre-Delgoffe;Maria Chikina;Rebekah E. Dadey;Hiroshi Yano

627
Citations
Interferon-γ: teammate or opponent in the tumour microenvironment?

Angela M Gocher;Creg J Workman;Dario A A Vignali

531
Citations
Adaptive plasticity of IL-10 + and IL-35 + T reg cells cooperatively promotes tumor T cell exhaustion

Deepali V Sawant;Deepali V Sawant;Hiroshi Yano;Maria Chikina;Qianxia Zhang;Qianxia Zhang

517
Citations
Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3

Creg J. Workman;Kari J. Dugger;Dario A. A. Vignali

486
Citations
The Development and Function of Regulatory T Cells

Creg J. Workman;Andrea L. Szymczak-Workman;Lauren W. Collison;Meenu R. Pillai

450
Citations
Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223).

Creg J. Workman;Dario A. A. Vignali

446
Citations
The CD4‐related molecule, LAG‐3 (CD223), regulates the expansion of activated T cells

Creg J. Workman;Dario A. A. Vignali

418
Citations
Lymphocyte Activation Gene-3 (CD223) Regulates the Size of the Expanding T Cell Population Following Antigen Activation In Vivo

Creg J. Workman;Linda S. Cauley;In-Jeong Kim;Marcia A. Blackman

394
Citations
Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor

Elisa Ruffo;Richard C. Wu;Tullia C. Bruno;Creg J. Workman

364
Citations
Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8+ T Cell-Derived Interferon-γ

Chang Liu;Maria Chikina;Rahul Deshpande;Ashley V. Menk

334
Citations
Generation of T-cell receptor retrogenic mice

Jeff Holst;Andrea L Szymczak-Workman;Kate M Vignali;Amanda R Burton

325
Citations
Single-cell RNA-seq and computational analysis using temporal mixture modelling resolves Th1/Tfh fate bifurcation in malaria

Tapio Lönnberg;Tapio Lönnberg;Valentine Svensson;Kylie R. James;Daniel Fernandez-Ruiz

296
Citations
Metalloproteases regulate T-cell proliferation and effector function via LAG-3

Nianyu Li;Yao Wang;Karen Forbes;Kate M Vignali

283
Citations

Frequent Co-Authors

Dario A. A. Vignali University of Pittsburgh

Drew M. Pardoll Johns Hopkins University School of Medicine

Charles G. Drake Columbia University

Tullia C. Bruno University of Pittsburgh

Peter Vogel St. Jude Children's Research Hospital

Kelli L. Boyd Vanderbilt University Medical Center

David Finkelstein St. Jude Children's Research Hospital

Richard J. Smeyne Thomas Jefferson University

Roland Tisch University of North Carolina at Chapel Hill

Prabir Ray University of Pittsburgh

External Links

Personal website of Creg J. Workman

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, several online degree programs offer flexible pathways into healthcare roles. For example, if you’re a Family Nurse Practitioner aiming to specialize further, an fnp to acute care np bridge program can provide the necessary training to transition smoothly.

Many aspiring nurses benefit from enrolling in an accelerated np program, which allows students to fast-track their education and start practicing sooner.

If you are new to the nursing field, there are excellent online accelerated nursing programs for non nurses designed to help non-nursing graduates gain essential clinical skills and credentials efficiently.

Additionally, some candidates look for the most accessible routes, making the easiest accelerated nursing programs to get into a viable option for entering the profession without excessive barriers.

Exploring these programs can open new doors in healthcare, blending immunological knowledge with nursing practice to enhance patient care and career potential.